CMA Detection

The CMA test of CapitalBio Technology uses Affymetrix GeneChip System 3000Dx and CytoScan 750K chip, it can not only provide accurate detection of chromosomal gene abnormalities, and provide an effective diagnostic basis for clinical birth defects, but also provide corresponding value-added services of prenatal data analysis and report interpretation, which is more convenient for clinicians' daily diagnosis and practical application.

Features of CMA Detection

ThermoFisher Affymetrix GeneChip System 3000Dx (GCS 3000Dx) chip system provides accurate and rapid birth defect diagnosis services. It is the most reliable platform for clinical research and the only chip system approved by the US FDA and China CFDA with EU IVD and CE marks, suitable for RNA and DNA-based clinical detection.

Product Coverage of CMA Detection

Prenatal detection and diagnosis of chromosomal abnormalities

Sample types: Peripheral blood, villi, amniotic fluid, cord blood and abortus

It can detect various chromosomal fetal chromosomal abnormalities, including copy number variation (CNV), uniparental diploidy (UPD), loss of heterozygosity (LOH), mosaicism, etc., such as Fancomi anemia or VACTERL syndrome caused by CNV; UPD caused Angelman syndrome, Prader Willi syndrome; and chromosomal abnormalities such as Autism, Cri-du-chat syndrome, Wolf Hirschhorn syndrome, Williams Beuren syndrome, etc.

Neonatal genetic disease diagnosis

Sample type: Peripheral Blood

Precise genetic diagnosis of children with birth defects such as mental retardation, developmental delay, polymorphism, autism, ADHD, epilepsy, neuromuscular disorders, and congenital heart disease

Specification of CMA Detection

For more information about transcriptome sequencing service and in vitro diagnostic assay, please feel free to contact us!